Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Top Stories > Illumina to divest cancer test maker Grail if it loses US or EU court appeal
    Top Stories

    Illumina to divest cancer test maker Grail if it loses US or EU court appeal

    Published by Uma Rajagopal

    Posted on October 12, 2023

    2 min read

    Last updated: January 31, 2026

    The image depicts Illumina's global headquarters in San Diego, California, amidst news of its potential divestiture of Grail, a cancer test maker. This situation follows regulatory pressures from the US and EU regarding antitrust issues.
    Illumina's headquarters in San Diego, California, related to Grail divestiture news - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:innovationfinancial managementcorporate strategy

    Quick Summary

    (Reuters) -Illumina Inc said on Wednesday it will divest cancer test maker Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or European courts.

    Illumina to divest cancer test maker Grail if it loses US or EU court appeal

    (Reuters) -Illumina Inc said on Wednesday it will divest cancer test maker Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or European courts.

    The company also said that if it wins both the cases, it will reassess Grail’s assets, which might result in integrating or divesting part or the entire unit.

    Reuters reported on Tuesday that Illumina is expected to get an order from EU antitrust later this week to sell Grail, which develops blood-based early cancer detection tests.

    Illumina completed its $7.1 billion takeover of Grail in August 2021, despite opposition from the European and U.S. regulators, and was fined a record 432 million euros ($458.65 million) by the EU earlier this year over the deal.

    The deal was opposed on concerns that the takeover would stifle competition in the U.S. market, giving Illumina an incentive to cut off Grail’s rivals from accessing the genetic testing company’s technology to develop early cancer detection tests.

    The U.S. Federal Trade Commission (FTC) has also ordered Illumina to divest Grail, which the San Diego, California-based company appealed against in June.

    The FTC, which enforces antitrust law in the United States, first filed a complaint in March 2021 to stop Illumina’s bid for its former subsidiary, Grail.

    In 2016, Illumina had spun off Grail, and retained a 12% stake.

    ($1 = 0.9419 euros)

    (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)

    Frequently Asked Questions about Illumina to divest cancer test maker Grail if it loses US or EU court appeal

    1What is divestment?

    Divestment is the process of selling off a subsidiary or an asset, often to reduce financial risk or comply with regulatory requirements.

    2What is antitrust law?

    Antitrust law is legislation enacted to prevent monopolies and promote competition in the marketplace, ensuring fair business practices.

    3What is a takeover?

    A takeover occurs when one company acquires control of another company, either by purchasing its shares or assets.

    4What is corporate strategy?

    Corporate strategy refers to the overall plan for a company to achieve its goals and objectives, including decisions about resource allocation and business direction.

    5What is early cancer detection?

    Early cancer detection involves identifying cancer at an initial stage when it is more treatable, often through screening tests or diagnostic procedures.

    More from Top Stories

    Explore more articles in the Top Stories category

    Image for Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Image for Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Image for Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Image for Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Image for Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Image for Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Image for Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Image for PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    Image for A Notable Update for Employee Health Benefits:
    A Notable Update for Employee Health Benefits:
    Image for Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Image for Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Image for ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    View All Top Stories Posts
    Previous Top Stories PostApollo to take Wagamama owner Restaurant Group private for $623 million
    Next Top Stories PostEricsson books $3 billion impairment, says Q3 core profit fell 39%